Skip to content

Melissa B Epperly, Director at Roivant Sciences, sold ROIV on Jun 29, 2026

Data as of Oct 16

▼ SELL$515K15,002 shares at $34.32Melissa B Epperly DirectorROIV Roivant Sciences Ltd.
Watch ROIV
Traded
Jun 29, 2026
Disclosed
Jul 1, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Melissa B Epperly, Director at Roivant Sciences, sold ROIV on Jun 29, 2026TRADEDDISCLOSED
ROIVSimilar stocks (XLV — its sector index fund), rebased to ROIV's price on the disclosure day
ROIV since disclosure
−4.3%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund

Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMelissa B Epperly DirectorROIV Roivant Sciences Ltd.$95.4Kdisclosed Jul 1 · filed 2 days after the trade

See every trade on ROIV →